CONMED | CNMD - Ebitda


CONMED reported $56.39M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
3M USD 1.42B 8M Mar/2026
Abbott USD 2.43B 844M Mar/2026
Accuray USD -685K 900K Sep/2024
AtriCure USD 17.07M 2.79M Mar/2026
Avanos Medical USD 13M 3M Dec/2025
Baxter International USD -447M 873M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
CONMED USD 56.39M 23.97M Mar/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
Intuitive Surgical USD 1.06B 29.9M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Merit Medical Systems USD 97.23M 17.69M Dec/2025
Olympus JPY 43.41B 2.31B Mar/2026
Orthofix International USD 27.88M 2.77M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
Smith & Nephew USD 796M 139M Dec/2025
Steris USD 394.7M 5M Dec/2025
Stryker USD 1.57B 618M Mar/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025